Genzyme's Sale of Testing Unit May Force Sanofi to Increase Takeover Offer
Bloomberg
Genzyme Corp., a takeover target of Sanofi-Aventis SA, agreed to sell its diagnostic testing unit to Laboratory Corp. of America Holdings for $925 million in cash. Sale of the unit,
Sanofi: Offer For Genzyme Remains At $69-a-share Wall Street Journal


Genzyme to Sell Genetic Lab Unit for $925 Million CNBC
LabCorp to Buy Genzyme Genetics for $925M In Sequence
Reuters India -WBUR -Xconomy
all 223 news articles »

 

Comments

Post a Comment
* Your Name:

* Your Email:

(NEVER publicly displayed)
Website URL:
* Security Image:
Security Image Generate New
Copy the numbers and letters from the security image:
 
* Your Comment:
No HTML tags are permitted in comments.
By submitting, you agree with our Publishing Policy. Please note that we may publish your comment in other sections of this site.